Les Weisbrod: Big Pharma Won't Police Itself (HuffingtonPost)
"FDA Criticized on Device Approvals" "FDA Is Lax on Oversight During Trials, Inquiry Finds" "In FDA Files, Claims of Rush to Approve Devices" "Financial Disclosures...

Mylan Receives Final FDA Approvals for Generic Versions of Lamictal(R) Tablets and Lamictal(R) CD (PR Newswire via Yahoo! Finance)
Mylan Inc. today announced that its subsidiaries Mylan Pharmaceuticals Inc. and Genpharm ULC received final approvals from the U.S. Food and Drug Administration for their Abbreviated New Drug Applications for Lamotrigine Tablets.

Study: Adding Vimpat significantly reduces partial-onset seizures in adults with epilepsy (EurekAlert!)
( Cooney Waters Group, Inc. ) Vimpat demonstrated greater seizure reduction and improved seizure freedom versus placebo when added to first and second-generation antiepileptic drugs. A phase III study supports recent US FDA and European Commission approvals of Vimpat.